Скачать презентацию Stock Options Compensation RCJ Chapter 15 842 -854

e602e9ce4d285528c6278733431bb9cc.ppt

• Количество слайдов: 18

Stock Options Compensation RCJ Chapter 15 (842 -854) Paul Zarowin

Key Issues 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. Intrinsic Value method Fair Value method Grant date Exercise price Vesting period Expiration period Expected life Volatility Repricing Footnote disclosures Pro-forma NI Option activity Options outstanding and exercisable Paul Zarowin 2

Employees’ Stock Options n Stock options have become a very pervasive vehicle in compensation of employees. n n Especially in the high growth industries, such as hi-tech. Offer employees the opportunity to purchase the firm’s common stock at a price (the exercise price) that is lower than the market price. Paul Zarowin 3

Key Terms and Variables variables in italics must be estimated; all others are observable n Grant date - date at which the options are granted to the n n n employee (usually the end of the year) Exercise price - price at which employee can buy the stock; the exercise price is usually set equal to the market price at the grant date Vesting period - period over which the employee first becomes eligible to exercise the options Expiration period - period after which the options lapse (i. e. , can no longer be exercised) expected life - expected time from grant date to exercise (must be \$vesting period and #expiration period) volatility - variance of the firm’s stock price Note: FV is a function of (exercise price, volatility, expected life, stock price, market interest rate) 4

Example of a Stock Option n n On Jan. 1 st 1998 IBM grants one of its employee an option to purchase 2, 000 stocks: n Vesting period of 3 years n Exercise price \$55 n Duration 10 years n Employee exercises option in 2002 How much money will the employee earn upon exercise of this option? Paul Zarowin 5

Grant date n n Option vested Option exercised Price on Jan 2002 is \$120 Employee earns: (\$120 -\$55) x 2, 000 =\$130, 000 ? Did the option have value on Jan. 1 st 1998 (when price was \$55)? Paul Zarowin 6

In, Out and At the Money Options can be: n “In the money”, i. e. , the exercise price is below the current stock price. n “Out of the money”, i. e. , the exercise price is above the current stock price. n “At the money”, i. e. , the exercise price is the same as the current stock price. n Employees’ stock options are typically granted at the money. Paul Zarowin 7

Accounting for Employees’ Stock Options Firms have choice of 2 methods: 1. IV (Intrinsic Value) Method (APB #25) – method most firms use to account for stock options: only recognize compensation expense if exercise price < market price @ grant date n must show footnote disclosure of pro-forma NI and EPS under the fair value method (and the option pricing method used along with the method’s relevant assumptions) 2. FV (Fair Value) Method (SFAS #123) – recognize compensation expense @ grant date equal to the FV of the options at that date Paul Zarowin 8

Intrinsic Value Method 3 a. Reprice (reset ex price) 1. grant @ 12/31 ex price = mkt price 3. Don’t exercise 3 b. Lapse 2. Exercise Paul Zarowin 9

Intrinsic Value Method (cont’d) 1. No compensation expense if exercise price market price; no accounting event, so no entry 2. Entry is: DR CR Cash xxx C/S xxx where xxx is the amount of cash collected (i. e. , the exercise price * # of shares) Ø Ø note: option exercise is a balance sheet event, a stock issuance at the exercise price, (no compensation expense) employee’s taxable income= #shares*(market price - exercise price); firm tax deduction is same 3 a. Firm recognizes compensation expense = # shares * (change in exercise price) 3 b. No accounting event, no entry Paul Zarowin 10

Intrinsic Value Method (cont’d) key points: 1. there is no effect on NI (no compensation expense) except 3 a (repricing) 2. real cost is dilution (reduction of EPS due to extra shares outstanding) or cash outflow (to repurchase shares to counteract dilution) correct exercise entry to show economic cost of options: DR Cash #shares*ex price DR Compensation expense #shares (mrk price-ex price) CR C/S #shares*mkt [email protected] Ex. E 15 -11, 15 Paul Zarowin 11

IV vs. FV Methods IV Method FV Method (a) ex pr < mkt pr @ grant 1. grant (b) ex pr mkt pr @ grant comp exp = #shrs*(mkt pr-ex pr) No event APC 2. exercise cash 4. reprice (d) ex pr < mkt pr @ grant ex pr mkt pr @ grant Comp exp - Determined by option pricing model Same as (C) APC Same as (A) C/S 3. lapse (c) Cash=cash received Same as (C) APC=offset CR from 1 No event Same as (A) Comp exp =#shrs*(ch in ex pr) Same as (A) Comp exp = in FV of options Same as (C) APC Paul Zarowin 12

Stock Option Footnote Disclosures 1. Existing options at B/S date a. outstanding options (usually grouped by range of ex prices) exercise price # outstanding Wt avg remaining life Wt avg ex price b. repeat for options currently exercisable 2. Option activity during the year # wt avg ex price options @ beginning of year + options granted - options exercised actual figures go here - options forfeited = options @ end of year 3. Option pricing method used and the method’s assumptions note: IV firms show pro-forma NI and EPS under FV method Ex. P 15 -6, C 15 -1 Paul Zarowin 13

Pure Accrual IV Method to Account for Stock Options (use options’ FMV to measure contingent liability and deferred compensation asset) 1. recognize options’ FMV at grant date as a contingent liability and deferred compensation asset 2. increase (or decrease) contingent liability and deferred compensation accounts as options’ FMV changes 3. amortize deferred compensation to compensation expense over specified service period 4. at exercise, extinguish contingent liability and record share issue at its MV 5. if lapse, extinguish contingent liability (if any value remains) and record increase in O/E (for uncompensated services received) Paul Zarowin 14

Pure Accrual IV Method – JEs (entries 1, 4, and 5 are transactions; entries 2 and 3 are adjustments @ EOY) DR CR amount 1. deferred compensation (B/S) contingent liability (B/S) options’ FMV 2. same as #1 (or reverse) change in FMV 3. compensation expense (I/S) def. compensation (B/S) amort. amount 4. cash (exercise price) C/S (market price) contingent liab. (mktpr–expr) 5. contingent liability APC remaining, unexercised value Paul Zarowin 15

Modified Accrual IV Method to Account for Stock Options (don’t know options’ FMV) (use difference between market price and exercise price to measure contingent liability and deferred compensation asset) 1. no entry at grant date if mkt. price = exercise price 2. recognize contingent liability and deferred compensation assets as stock price rises above exercise price; 2 a. increase (or decrease) contingent liability and deferred compensation accounts as stock price changes 3. amortize deferred compensation to compensation expense over specified service period 4. at exercise, extinguish contingent liability and record share issue at its MV 5. if lapse, extinguish contingent liability (if any value remains) and record increase in O/E (for uncompensated services received) Paul Zarowin 16

Modified Accrual IV – JEs (entries 4 and 5 are transactions; others are adjustments @ EOY) DR CR amount 1. no entry if mkt price = exercise price 2. def. compensation(B/S) contingent liability (B/S) excess of mktpr - expr 2 a. same as #1 (or reverse) change in mktpr 3. compensation exp (I/S) def. compensation (B/S) amort. amount 4. cash (exercise price) C/S (market price) contingent liab (mktpr–expr) 5. contingent liability APC remaining, unexercised value Paul Zarowin 17

Modified Accrual IV, JEs - Cont’d correction entry* DR CR Deferred compensation asset xxx contingent liability xxx = (market price – exercise price) x # of outstanding in the money options; often referred to as option overhang, amount of loss incurred if all outstanding options were exercised at current price; conservative liability estimate, because it ignores price rise; can discount it for probability of non-exercise and tax benefits of exercise * overstates O/E, because it doesn’t account for amortized Deferred compensation asset, which is difficult to estimate Paul Zarowin 18